Novartis acquires Kedalion Therapeutics

“I’ve had the fortunate opportunity  to work closely with Mark Murray of FLG Partners in a series of  four  successful venture backed -backed companies in Silicon Valley  over the past dozen years including Optimedica Corporation (acquired by Abbott), Oculeve (acquired by Allergan), Oyster Point Pharmaceuticals (IPO) and most recently Kedalion Therapeutics (acquired by Novartis). I consider him to be the  consummate professional and invaluable  in providing state of the art financial management and strategic advising  for young rapidly growing  drug and medical device companies. Mark has a wealth of experience and considerable savvy in a variety of different situations and market conditions, whether it be in developing a strategic plan, raising capital, optimizing operations or helping identify and manage liquidity events. In my mind he is an absolute go-to thinker and do-er for any company looking to attract top level management talent.”